Accelerating Implementation of Long-Acting Injectables
RWHAP Technical Assistance Provider updated on 03/06/2024
RWHAP Technical Assistance Provider updated on 03/06/2024
Resource updated 04/12/2024
Blog updated 12/22/2022
Resource (Conference Presentation) updated 09/14/2023
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 12/19/2023
Resource updated 09/19/2023
Resource updated 05/11/2023
Resource updated 04/07/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023